Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Artiva Biotherapeutics (ARTV) Gains from Investment Securities (2023 - 2025)

Artiva Biotherapeutics (ARTV) has disclosed Gains from Investment Securities for 3 consecutive years, with $344000.0 as the latest value for Q4 2025.

  • For Q4 2025, Gains from Investment Securities rose 1209.68% year-over-year to $344000.0; the TTM value through Dec 2025 reached $377000.0, changed N/A, while the annual FY2025 figure was $2.6 million, N/A changed from the prior year.
  • Gains from Investment Securities hit $344000.0 in Q4 2025 for Artiva Biotherapeutics, down from $1.2 million in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $1.2 million in Q3 2025 and bottomed at -$45000.0 in Q4 2023.
  • Average Gains from Investment Securities over 3 years is $288615.5, with a median of $132349.0 recorded in 2024.
  • Year-over-year, Gains from Investment Securities surged 31.11% in 2024 and then surged 1209.68% in 2025.
  • Artiva Biotherapeutics' Gains from Investment Securities stood at -$45000.0 in 2023, then soared by 31.11% to -$31000.0 in 2024, then soared by 1209.68% to $344000.0 in 2025.
  • According to Business Quant data, Gains from Investment Securities over the past three periods came in at $344000.0, $1.2 million, and $155698.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.